Information Provided By:
Fly News Breaks for May 25, 2016
ILMN, QGEN
May 25, 2016 | 15:12 EDT
Piper Jaffray analyst William Quirk said patent infringement outcomes are hard to predict, but added that Illumina's (ILMN) win at the Patent Trial and Appeal Board increase its chances to prevail in its recently filed infringement lawsuit against Qiagen (QGEN) related to the GeneReader DNA sequencer. If Illumina does win, Qiagen will need to "drastically" alter the product and/or remove it from the market, said Quirk, who keeps a Neutral rating on Qiagen shares.
News For QGEN;ILMN From the Last 2 Days
There are no results for your query QGEN;ILMN